BOSTON SCIENTIFIC CORP

BSX 10-K · Q4 2025
API behind this page

BSX Q4 2025 request

Playground key active
Request URL /api/financials?ticker=BSX&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 5,286 4,561 +15.9%
Show Geography breakouts
Emerging Markets 771 668 +15.4%
Non Us 1,901 1,669 +13.9%
US 3,385 2,893 +17.0%
Show — breakouts
Revenue 586 566 +3.5%
Revenue -321 -310 -3.5%
Revenue -839 -837 -0.2%
Revenue 890 649 +37.1%
Revenue 1,245 202 +516.3%
Revenue 335 -10 +3450.0%
Revenue -4,801 -3,361 -42.8%
Revenue -5,915 -4,397 -34.5%
Revenue -6,602 -5,012 -31.7%
Revenue -958 -890 -7.6%
Revenue -3,904 -2,605 -49.9%
Revenue -4,533 -3,193 -42.0%
Revenue 717 630 +13.8%
Revenue -2,818 -1,895 -48.7%
Revenue -4,109 -2,809 -46.3%
Revenue 2,525 2,222 +13.6%
Revenue -107 -370 +71.1%
Revenue 2,118 2,119 -0.0%
Revenue -1,118 -1,121 +0.3%
Revenue -568 -406 -39.9%
Revenue -2,518 -2,257 -11.6%
Revenue 212 -197 +207.6%
Revenue 725 317 +128.7%
Revenue -512 -513 +0.2%
Revenue -1,330 -1,161 -14.6%
Revenue -4,764 -3,263 -46.0%
Revenue -901 222 -505.9%
Revenue -3,894 -2,438 -59.7%
Revenue 9,478 7,319 +29.5%
Revenue -2,949 -1,820 -62.0%
Revenue 179 155 +15.5%
Revenue 788 684 +15.2%
Revenue 2,772 2,570 +7.9%
Cost of Revenue 1,608 1,466 +9.7%
Gross Profit 3,679 3,095 +18.9%
Selling, General & Administrative 1,834 1,612 +13.8%
Research And Development Expense Excluding Acquired In Process Cost 569 459 +24.0%
Royalty Expense 6 9 -33.3%
Amortization Of Intangible Assets 228 225 +1.3%
Impairment Of Intangible Assets Excluding Goodwill 0 110 -100.0%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 7 -1 +800.0%
Restructuring Charges 16 4 +300.0%
Operating Expenses 2,854 2,420 +17.9%
Show Consolidation Items breakouts
Corporate Non Segment 179 223 -19.7%
Operating Income 825 675 +22.2%
Interest Expense -90 -80 -12.5%
Other Nonoperating Income Expense Net -35 -9 -288.9%
Income Before Taxes 700 585 +19.7%
Income Tax Expense (Benefit) 30 23 +30.4%
Net Income 670 562 +19.2%
Show Equity Components breakouts
Retained Earnings 670 562 +19.2%
Net Income Loss Attributable To Noncontrolling Interest -2 -4 +50.0%
Show Equity Components breakouts
Noncontrolling Interest -2 -4 +50.0%
Net Income Loss Available To Common Stockholders Basic 672 565 +18.9%
EPS (Basic) 0.46 0.38 +21.1%
EPS (Diluted) 0.45 0.38 +18.4%
Wtd Avg Shares (Basic) 0.8 0.9 -11.1%
Wtd Avg Shares (Diluted) 0.5 1.4 -64.3%
Other Non-Operating Income (Expense) -125 -90 -38.9%
Comprehensive Income 751 969 -22.5%
Foreign Currency Transaction Gain Loss Before Tax (Q) — — —
Show Hedging Designation breakouts
Nondesignated · Other Nonoperating Income Expense -10 -64 +84.4%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax (Q) — — —
Show Derivative Risk breakouts
Foreign Exchange Contract · Designated As Hedging Instrument 38 125 -69.6%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 1,965 414 +374.6%
Accounts Notes And Loans Receivable Net Current 2,926 2,558 +14.4%
Inventory 2,943 2,810 +4.7%
Prepaid Taxes 299 307 -2.6%
Prepaid Expenses & Other Current Assets 660 831 -20.6%
Total Current Assets 8,794 6,920 +27.1%
Non-Current Assets
Property, Plant & Equipment 4,036 3,294 +22.5%
Goodwill 18,282 17,089 +7.0%
Show Business Segments breakouts
Cardiovascular 10,574 9,606 +10.1%
MedSurg 7,709 7,483 +3.0%
Show Business Acquisition breakouts
All Other 507 — —
Deferred Tax Assets 3,675 3,655 +0.5%
Other Non-Current Assets 1,866 1,754 +6.4%
Total Assets 43,673 39,395 +10.9%
Operating Lease Right-of-Use Assets 465 449 +3.6%
Other Assets
Intangible Assets Net Excluding Goodwill 7,019 6,684 +5.0%
Current Liabilities
Debt Current 299 1,778 -83.2%
Accounts Payable 1,144 960 +19.2%
Accrued Liabilities 3,201 2,773 +15.4%
Other Liabilities Current 795 887 -10.4%
Total Current Liabilities 5,439 6,399 -15.0%
Deferred Revenue 313 306 +2.3%
Non-Current Liabilities
Deferred Tax Liabilities 220 155 +41.9%
Other Non-Current Liabilities 2,405 1,870 +28.6%
Long-Term Debt (Q) — — —
Show Long-Term Debt Type breakouts
Capital Lease Obligations 125 126 -0.8%
December 2027 Notes 1,058 935 +13.2%
January 2040 Notes 300 300 0.0%
June 2030 Notes 1,200 1,200 0.0%
March 2028 Notes 344 344 0.0%
March 2028 Senior Notes 881 779 +13.1%
March 2029 Euro Senior Notes 881 779 +13.1%
March 2029 Notes 272 272 0.0%
March 2031 Notes 881 779 +13.1%
March 2031 Notes 2 999 — —
March 2032 Euro Senior Notes 1,469 1,299 +13.1%
March 2034 Notes 588 519 +13.3%
March 2034 Notes 2 764 — —
March 2039 Notes 450 450 0.0%
March 2049 Notes 650 650 0.0%
November 2019 Aggregate Offering 900 900 0.0%
November 2035 Notes 350 350 0.0%
Senior Notes 11.34 10.45 +8.5%
Operating Lease Liabilities 446 401 +11.2%
Other Liabilities
Long Term Debt And Capital Lease Obligations 11,137 8,968 +24.2%
Minority Interest 239 233 +2.6%
Stockholders' Equity
Common Stock 17 17 0.0%
Treasury Stock Value -2,251 -2,251 0.0%
Additional Paid In Capital Common Stock 21,505 21,056 +2.1%
Retained Earnings 5,571 2,673 +108.4%
Accumulated Other Comprehensive Income -610 275 -321.8%
Total Stockholders' Equity 24,233 21,770 +11.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -2 -16 +87.5%
Accumulated Gain Loss Net Cash Flow Hedge Parent -48 155 -131.0%
Accumulated Other Comprehensive Income -610 275 -321.8%
Accumulated Translation Adjustment -561 136 -512.5%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 24,472 22,003 +11.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -610 275 -321.8%
Additional Paid In Capital 21,505 21,056 +2.1%
Common Stock 17 17 0.0%
Noncontrolling Interest 239 233 +2.6%
Parent 24,233 21,770 +11.3%
Retained Earnings 5,571 2,673 +108.4%
Treasury Stock Common -2,251 -2,251 0.0%
Total Liabilities & Equity 43,673 39,395 +10.9%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 365 348 +4.9%
Cash Flow Impact Of Deferred Income Tax Expense Benefit -22 -80 +72.5%
Stock-Based Compensation 71 69 +2.9%
Gain Loss On Investments 42 19 +121.1%
Tangible Asset Impairment Charges 51 42 +21.4%
Other Operating Activities Cash Flow Statement 20 10 +100.0%
Change in Accounts Receivable -98 -90 -8.9%
Change in Inventory -50 46 -208.7%
Increase Decrease In Other Operating Assets 18 -17 +205.9%
Increase Decrease In Accounts Payable And Accrued Liabilities 285 385 -26.0%
Net Cash from Operations 1,364 1,456 -6.3%
Investing Activities
Capital Expenditures -351 -277 -26.7%
Payments To Acquire Businesses Net Of Cash Acquired -89 -3,418 +97.4%
Proceeds From Payments For Investments And Acquisitions Of Certain Technologies -74 -16 -362.5%
Other Investing Activities 73 6 +1116.7%
Net Cash from Investing -512 -3,704 +86.2%
Financing Activities
Payment For Contingent Consideration Liability Financing Activities 0 0 —
Finance Lease Principal Payments -209 0 —
Repayments Of Short Term Debt 0 0 —
Proceeds From Issuance Of Senior Long Term Debt 0 0 —
Paymenttonetsharesettleemployeeequityawards -3 -4 +25.0%
Proceeds From Stock Plans 20 28 -28.6%
Proceeds From Payments For Other Financing Activities 9 3 +200.0%
Net Cash from Financing -184 214 -186.0%
Supplemental
Restricted Cash And Cash Equivalents At Carrying Value 80 111 -27.9%
Restricted Cash Equivalents Noncurrent 103 80 +28.7%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3 -9 +133.3%
Net Change in Cash 671 -2,044 +132.8%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,147 606 +254.3%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key